Tustin, CA, United States of America

Wendy M Blanda

This inventor holds 30 USPTO granted patents and 28 published patent applications, plus 9 CIPO patents and 11 EPO patents, primarily in Ocular Drug Delivery. Top assignee: Allergan, Inc.. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wendy M Blanda. Retrieved from https://idiyas.com/inventor/wendy-m-blanda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 6.2

ph-index = 10

Forward Citations = 353(Granted Patents)


Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Biodegradable Implants
Intravitreal Tyrosine Kinase
Ocular Drug Delivery
Sustained Release
Dermal Filler
Steroid-Containing Implants
Botulinum Toxin
Alpha-2 Agonist
Atrophic Macular Degeneration
Extrusion Process
Cyclosporin A
Joint Fat Pad Formulations
30 patents (USPTO):Explore Patents

Title: Wendy M Blanda - Innovative Inventor from Tustin

Introduction: Wendy M Blanda is a talented inventor based in Tustin, California, known for her groundbreaking contributions to various industries.

Latest Patents: Wendy M Blanda holds several patents in the fields of technology and healthcare, showcasing her diverse range of expertise and innovative mindset.

Career Highlights: With a successful career spanning over two decades, Wendy M Blanda has consistently pushed the boundaries of innovation, leading to significant advancements in her respective fields.

Collaborations: Throughout her career, Wendy M Blanda has collaborated with top industry professionals, research institutions, and universities to further enhance her inventions and bring them to market successfully.

Conclusion: Wendy M Blanda's passion for innovation and her relentless drive to create have solidified her reputation as a pioneering inventor in Tustin and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…